2. Academic Validation
  3. Complete remission of NUP98 fusion-positive acute myeloid leukemia with the covalent menin inhibitor BMF-219, icovamenib

Complete remission of NUP98 fusion-positive acute myeloid leukemia with the covalent menin inhibitor BMF-219, icovamenib

  • Haematologica. 2025 Apr 1;110(4):1041-1046. doi: 10.3324/haematol.2024.286537.
Hetty E Carraway 1,  Joy Nakitandwe 2,  Alexandru Cacovean 3,  Yan Ma 3,  Brian Munneke 3,  Ganesh Waghmare 3,  Clarissa Mandap 3,  Uzma Ahmed 3,  Nicole Kowalczyk 3,  Thomas Butler 3,  Stephan W Morris 3
Affiliations

Affiliations

  • 1 Department of Hematology and Medical Oncology, Taussig Cancer Center Institute, Cleveland Clinic, Cleveland, OH. carrawh@ccf.org.
  • 2 Department of Pathology and Laboratory Medicine, Diagnostics Institute, Cleveland Clinic, Cleveland OH.
  • 3 Biomea Fusion, Inc., Redwood City, CA.
PMID: 39633542 DOI: 10.3324/haematol.2024.286537
Figures
Products